BioSpace News Archive

Corvus Pharmaceuticals, Inc. announced that it will present new data for CPI-818, the Company’s ITK inhibitor, at the American Association for Cancer Research Annual Meeting, which is taking place April 14-19, 2023 in Orlando, FL.

Quanta Therapeutics announced the acceptance of two late-breaking abstracts for presentation at the American Association for Cancer Research Annual Meeting being held April 14-19, 2023, in Orlando, Florida.

Erasca, Inc., a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, announced the company will present a poster presentation at the upcoming American Association for Cancer Research Annual Meeting, taking place April 14-19, 2023, in Orlando, Florida.

23andMe Holding Co. announced that clinical data from the Phase 1 portion of the Phase 1/2a study of 23ME-00610 has been selected for a poster presentation at the American Association for Cancer Research Annual Meeting being held in Orlando, Florida, April 14-19, 2023.

Cullinan Oncology, Inc., (Nasdaq: CGEM) (“Cullinan Oncology”) today announced that posters of preclinical data highlighting the therapeutic potential of two assets, CLN-619 and CLN-617, will be presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting taking place in Orlando, Florida, April 14-17, 2023.

Merus N.V. announced the selection of an abstract for a plenary session oral presentation that will highlight interim clinical data on the bispecific antibody petosemtamab in previously treated HNSCC along with the selection of a second abstract on petosemtamab in advanced gastric/esophageal adenocarcinoma for poster presentation at the AACR Annual Meeting 2023 taking place in Orlando, Florida April 14-19, 2023.

Merus N.V. announced the publication of an abstract highlighting the preclinical evaluation of the bispecific antibody MCLA-129 for poster presentation at the American Association for Cancer Research Annual Meeting 2023 taking place in Orlando, Florida April 14-19, 2023.

Affimed N.V. announced that two abstracts with clinical and preclinical data on AFM13, its anti-CD30 targeting innate cell engager, have been accepted for presentation at the Annual Meeting of the American Association for Cancer Research, taking place April 14-19, 2022 in Orlando, Florida.

HotSpot Therapeutics, Inc. today announced it will present two poster presentations on the company’s CBL-B program at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19, 2023, in Orlando, FL.

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company, today announced that an abstract highlighting pre-clinical data for CRB-601, its avβ8 blocking antibody, has been accepted for presentation at a poster at the 2023 American Association for Cancer Research (AACR) annual meeting, to be held April 14-19, 2023 in Orlando, Fl.